Chronic obstructive pulmonary disease (COPD) affects approximately 29 million people in the U.S. and is the fourth leading ...

Angiotensin-converting enzyme (ACE) inhibitor therapy may reduce all-cause mortality in idiopathic pulmonary fibrosis (IPF) but not in COPD.

Regardless of blood eosinophil count threshold, adults with COPD and an eosinophilic phenotype experienced significantly fewer moderate/severe exacerbations in a year with mepolizumab vs. placebo, ...

For patients with AECOPD admitted to the ICU, lower eosinophil counts are associated with increased in-hospital mortality.

I was diagnosed with COPD last year after struggling with multiple symptoms. I quit smoking over 10 years ago, but I’m ...

A single-inhaler triple therapy improved lung function in adults and adolescents with inadequately controlled asthma and was ...